Farmers’ protests that swept across Europe in 2024 were driven by a wide range of concerns that differ markedly between countries, according to a new study led by researchers at the University of Göttingen. Based on survey responses from more than 2,200 farmers in Germany, France, Belgium, and the Netherlands, the study finds that farmers’ motivations go far beyond commonly cited issues such as environmental regulations. Instead, complaints range from bureaucracy and low incomes to political dissatisfaction and uncertainty about the future of farming. The findings also suggest that policy responses at national and EU level only partly reflect farmers’ actual priorities. The results were published in the journal Food Policy.

A new study shows that generative AI is already being used to “bring back” the dead, as entertainment icons, as political witnesses, and as everyday companions for grieving families. Tracing cases of AI “resurrections,” the study claims this practice isn’t just emotionally powerful; it’s ethically explosive because it turns a person’s voice, face, and life history into reusable raw material. AI resurrections are important because they can happen with little or no consent, clear ownership rules, or accountability, creating a new kind of exploitation the authors call “spectral labor,” where the dead become an involuntary source of data and profit, while the living are left to navigate blurred lines between memory and manipulation, comfort and coercion, tribute and abuse.

Excitement is building for FIFA World Cup soccer games in Toronto and Vancouver in June and July, yet Canada’s overburdened health systems may buckle with any additional demand, cautions an editorial published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.252094.

Analysis of the medical records of 1,269 elderly patients with advanced cancer by researchers at University of Tsukuba has found that more than 70% were prescribed potentially inappropriate medications (PIMs) and that the prescription rate declined closer to the patient's death. Discontinuation was more frequent among patients admitted to palliative care units, those with polypharmacy, and females. These findings may help reduce treatment burden among patients nearing the end of their life.